<i>NPR2</i> Variants Are Frequent among Children with Familiar Short Stature and Respond Well to Growth Hormone Therapy

Abstract

NPR2 gene variants cause FSS in a significant proportion of children. Their GH treatment response is promising. Studies including final height data are necessary to assess the long-term efficacy of this therapy.